Serum expression levels of MEG3 and microRNA-147b, as non-coding RNA biomarkers, were measured across four equally subcategorized groups (patients with and without dyslipidemia (N = 66) and healthy controls with and without dyslipidemia (N = 66) using Polymerase Chain Reaction (PCR). This evidence concerns the gene MEG3 and metabolic syndrome.